Clinical Scorecard: Correlation of In Vivo and Ex Vivo Photon-Counting CT Assessments of Subchondral Trabecular Bone Characteristics in Knee Osteoarthritis Patients

At a Glance

Key Highlights

• Photon-counting CT (PCCT) offers ultra-high-resolution in vivo imaging of subchondral bone microstructure comparable to ex vivo imaging modalities.
• Correlation and agreement between in vivo and ex vivo PCCT measurements of bone volume fraction, trabecular thickness, attenuation, and sclerosis area were investigated in knee OA patients.
• Non-invasive PCCT imaging enables potential longitudinal studies to track bone changes and evaluate disease-modifying OA drugs targeting bone.

Guideline-Based Recommendations

Diagnosis

• Use photon-counting CT for high-resolution imaging of subchondral trabecular bone in knee OA patients.
• Apply adaptive thresholding methods (e.g., Otsu method) for accurate bone microstructure segmentation.

Management

• Consider imaging bone microstructure changes to understand OA progression and evaluate bone-targeting therapies.
• Recognize current bone-acting agents have not shown significant effects on OA structural progression.

Monitoring & Follow-up

• Utilize PCCT for longitudinal monitoring of subchondral bone changes in vivo with minimal radiation exposure.
• Perform quantitative assessments including bone volume fraction, trabecular thickness, and sclerosis area.

Risks

• Radiation exposure from CT scans should be minimized and justified; PCCT allows clinically acceptable doses with high resolution.
• Interpretation of bone changes should consider limitations in contrast and resolution compared to ex vivo imaging.

Patient & Prescribing Data

Patients with severe knee OA and obesity undergoing knee arthroplasty

Current bone-modulating medications (bisphosphonates, calcitonin, strontium ranelate) have not demonstrated significant impact on OA progression; imaging advances may facilitate future therapeutic evaluation.

Clinical Best Practices

• Perform in vivo PCCT scans using ultra-high-resolution mode with standardized acquisition parameters for reproducibility.
• Register ex vivo and in vivo scans using rigid and affine transformations to enable voxel-to-voxel comparisons.
• Manually segment sclerosis areas blinded to clinical data to reduce bias.
• Use multiple regions of interest in healthy and sclerotic bone for attenuation measurement in Hounsfield Units.
• Apply iterative reconstruction algorithms to optimize image quality while maintaining acceptable radiation dose.

References

• The INKA trial ClinicalTrials.gov Identifier: NCT05172843
• ITK-SNAP software
• 3D Slicer software